Evaluation of Efficacy and Safety of Intradiscal Gelified Ethanol in Refractory Cervical Discogenic Pain

Exclusion Criteria

• •Prior surgical treatment of the disc(s) studied;
• •Sick leave of more than 12 months secondary to painful symptoms;
• •Patient with Modic 1 score or more
• •History of cognitive-behavioral disorders that could affect the completion of self-questionnaires;
• •Local or systemic infection, or suspicion of infection;
• •Severe coagulation disorders;
• •Other inflammatory rheumatic disease;
• •Severe underlying pathology with life expectancy \<1 year;
• •Women of childbearing age who are pregnant at the inclusion visit or who wish to become pregnant before the administration of the treatment (V0);
• •Known allergy to contrast material and/or local anesthetic substances;
• •Patients who cannot read or write Italian;
• •Major person benefiting from a legal protection regime (guardianship, curatorship, safeguard of justice);